Cancer Research UK logo.
SearchDonate
  • Search

A study of gamma delta T cells for advanced melanoma, renal cell kidney cancer or non small cell lung cancer

Overview

Cancer types:

Kidney cancer, Lung cancer, Melanoma, Non small cell lung cancer (NSCLC), Renal cell cancer, Secondary cancers, Skin cancer

Status:

Closed

Phase:

Phase 1/2

Details

This study is looking at the safety and usefulness of a new treatment called ImmuniCell that boosts the immune system.

It is open to people with melanoma skin cancer, renal cell kidney cancer or non small cell lung cancer:

  • that has spread to another part of the body (advanced cancer) or

  • is slow growing and your doctors thinks this treatment might help

Recruitment start: 1 December 2015

Recruitment end: 27 November 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jeff Evans

Supported by

TC BioPharm

Last reviewed: 4 December 2018

CRUK internal database number: 14098

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.